CYP2D6 and CYP2C19 genotype‐based dose recommendations for antidepressants: a first step towards subpopulation‐specific dosages J Kirchheiner, K Brøsen, ML Dahl, LF Gram, S Kasper, I Roots, F Sjöqvist, ... Acta Psychiatrica Scandinavica 104 (3), 173-192, 2001 | 569 | 2001 |
Relationship between plasma desipramine levels, CYP2D6 phenotype and clinical response to desipramine: a prospective study E Spina, C Gitto, A Avenoso, GM Campo, AP Caputi, E Perucca European journal of clinical pharmacology 51, 395-398, 1997 | 156 | 1997 |
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: clinical relevance of IgG isotype A Cortese, R Lombardi, C Briani, I Callegari, L Benedetti, F Manganelli, ... Neurology: Neuroimmunology & Neuroinflammation 7 (1), e639, 2019 | 142 | 2019 |
Adjunctive fluoxetine in the treatment of negative symptoms in chronic schizophrenic patients E Spina, P De Domenico, C Ruello, N Longobardo, C Gitto, M Ancione, ... International clinical psychopharmacology 9 (4), 281-286, 1994 | 139 | 1994 |
Inhibition of desmethylimipramine 2-hydroxylation by drugs in human liver microsomes C Von Bahr, E Spina, C Birgersson, Ö Ericsson, M Göransson, T Henthorn, ... Biochemical pharmacology 34 (14), 2501-2505, 1985 | 111 | 1985 |
CYP2D6 genotype and antipsychotic-induced extrapyramidal side effects in schizophrenic patients MG Scordo, E Spina, P Romeo, ML Dahl, L Bertilsson, I Johansson, ... European journal of clinical pharmacology 56, 679-683, 2000 | 107 | 2000 |
Prescribing patterns of antiepileptic drugs in Italy: a nationwide population‐based study in the years 2000–2005 R Savica, E Beghi, G Mazzaglia, F Innocenti, O Brignoli, C Cricelli, ... European Journal of Neurology 14 (12), 1317-1321, 2007 | 100 | 2007 |
The COVID-19 infection in Italy: a statistical study of an abnormally severe disease G De Natale, V Ricciardi, G De Luca, D De Natale, G Di Meglio, ... Journal of clinical medicine 9 (5), 1564, 2020 | 89 | 2020 |
Interaction between fluvoxamine and imipramine/desipramine in four patients E Spina, GM Campo, A Avenoso, MA Pollicino, AP Caputi Therapeutic drug monitoring 14 (3), 194-196, 1992 | 86 | 1992 |
A four-year longitudinal study on restless legs syndrome in Parkinson disease M Moccia, R Erro, M Picillo, G Santangelo, E Spina, R Allocca, K Longo, ... Sleep 39 (2), 405-412, 2016 | 83 | 2016 |
Gender differences in non-motor symptoms in early Parkinson's disease: a 2-years follow-up study on previously untreated patients M Picillo, R Erro, M Amboni, K Longo, C Vitale, M Moccia, A Pierro, ... Parkinsonism & related disorders 20 (8), 850-854, 2014 | 76 | 2014 |
Inhibition of desipramine 2‐hydroxylation by quinidine and quinine E Steiner, E Dumont, E Spina, R Dahlqvist Clinical Pharmacology & Therapeutics 43 (5), 577-581, 1988 | 76 | 1988 |
Carbamazepine coadministration with fluoxetine or fluvoxamine A Avenoso, AM Pollicino, AP Caputi, A Fazio, F Pisani Therapeutic drug monitoring 15 (3), 247-250, 1993 | 73 | 1993 |
Interaction of carbamazepine‐10, 11‐epoxide, an active metabolite of carbamazepine, with valproate: a pharmacokinetic study F Pisani, M Caputo, A Fazio, G Oteri, M Russo, E Spina, E Perucca, ... Epilepsia 31 (3), 339-342, 1990 | 47 | 1990 |
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? M Moccia, M Picillo, R Erro, C Vitale, K Longo, M Amboni, G Santangelo, ... Parkinsonism & related disorders 20 (7), 772-775, 2014 | 46 | 2014 |
Effect of ketoconazole on the pharmacokinetics of imipramine and desipramine in healthy subjects E Spina, A Avenoso, GM Campo, MG Scordo, AP Caputi, E Perucca British journal of clinical pharmacology 43 (3), 315-318, 1997 | 41 | 1997 |
The neuropathy in hereditary transthyretin amyloidosis: A narrative review S Tozza, D Severi, E Spina, A Iovino, F Aruta, L Ruggiero, R Dubbioso, ... Journal of the Peripheral Nervous System 26 (2), 155-159, 2021 | 40 | 2021 |
Carbamazepine induced bradycardia-a problem in general or only in susceptible patients? A 24-h long-term electrocardiogram study G Kennebäck, L Bergfeldt, T Tomson, E Spina, O Edhag Epilepsy research 13 (2), 141-145, 1992 | 38 | 1992 |
Single dose pharmacokinetics of carbamazepine-10, 11-epoxide in patients on lamotrigine monotherapy F Pisania, B Xiao, A Fazio, E Spina, E Perucca, T Tomson Epilepsy research 19 (3), 245-248, 1994 | 34 | 1994 |
Speech discrimination is impaired in parkinsonian patients: Expanding the audiologic findings of Parkinson's disease C Vitale, V Marcelli, T Abate, A Pianese, R Allocca, M Moccia, E Spina, ... Parkinsonism & related disorders 22, S138-S143, 2016 | 33 | 2016 |